These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35978536)

  • 21. Activation profile of Toll-like receptors of peripheral blood lymphocytes in patients with systemic lupus erythematosus.
    Wong CK; Wong PT; Tam LS; Li EK; Chen DP; Lam CW
    Clin Exp Immunol; 2010 Jan; 159(1):11-22. PubMed ID: 19843090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Immunometabolism and systemic lupus erythematosus].
    Xiao YB; Guo MY; Zuo XX
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):1120-1124. PubMed ID: 30562794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease.
    Lood C; Blanco LP; Purmalek MM; Carmona-Rivera C; De Ravin SS; Smith CK; Malech HL; Ledbetter JA; Elkon KB; Kaplan MJ
    Nat Med; 2016 Feb; 22(2):146-53. PubMed ID: 26779811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. VDAC oligomers form mitochondrial pores to release mtDNA fragments and promote lupus-like disease.
    Kim J; Gupta R; Blanco LP; Yang S; Shteinfer-Kuzmine A; Wang K; Zhu J; Yoon HE; Wang X; Kerkhofs M; Kang H; Brown AL; Park SJ; Xu X; Zandee van Rilland E; Kim MK; Cohen JI; Kaplan MJ; Shoshan-Barmatz V; Chung JH
    Science; 2019 Dec; 366(6472):1531-1536. PubMed ID: 31857488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Innate Immune Cells' Contribution to Systemic Lupus Erythematosus.
    Herrada AA; Escobedo N; Iruretagoyena M; Valenzuela RA; Burgos PI; Cuitino L; Llanos C
    Front Immunol; 2019; 10():772. PubMed ID: 31037070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IFNα Impairs Autophagic Degradation of mtDNA Promoting Autoreactivity of SLE Monocytes in a STING-Dependent Fashion.
    Gkirtzimanaki K; Kabrani E; Nikoleri D; Polyzos A; Blanas A; Sidiropoulos P; Makrigiannakis A; Bertsias G; Boumpas DT; Verginis P
    Cell Rep; 2018 Oct; 25(4):921-933.e5. PubMed ID: 30355498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apoptosis and mitochondrial dysfunction in lymphocytes of patients with systemic lupus erythematosus.
    Perl A; Nagy G; Gergely P; Puskas F; Qian Y; Banki K
    Methods Mol Med; 2004; 102():87-114. PubMed ID: 15286382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dendritic cells in systemic lupus erythematosus: From pathogenesis to therapeutic applications.
    Liu J; Zhang X; Cao X
    J Autoimmun; 2022 Oct; 132():102856. PubMed ID: 35773101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased oxidative stress contributes to impaired peripheral CD56
    Lu Z; Tian Y; Bai Z; Liu J; Zhang Y; Qi J; Jin M; Zhu J; Li X
    Arthritis Res Ther; 2022 Feb; 24(1):48. PubMed ID: 35172900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelets and IgE: Shaping the Innate Immune Response in Systemic Lupus Erythematosus.
    Brilland B; Scherlinger M; Khoryati L; Goret J; Duffau P; Lazaro E; Charrier M; Guillotin V; Richez C; Blanco P
    Clin Rev Allergy Immunol; 2020 Apr; 58(2):194-212. PubMed ID: 31254159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
    Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
    Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunometabolism in systemic lupus erythematosus: Relevant pathogenetic mechanisms and potential clinical applications.
    Tzeng HT; Chyuan IT
    J Formos Med Assoc; 2021 Sep; 120(9):1667-1675. PubMed ID: 33836940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of mitochondrial dysfunction in lymphocytes of patients with systemic lupus erythematosus.
    Perl A; Hanczko R; Doherty E
    Methods Mol Biol; 2012; 900():61-89. PubMed ID: 22933065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of dead cell clearance in the etiology and pathogenesis of systemic lupus erythematosus: dendritic cells as potential targets.
    Biermann MH; Veissi S; Maueröder C; Chaurio R; Berens C; Herrmann M; Munoz LE
    Expert Rev Clin Immunol; 2014 Sep; 10(9):1151-64. PubMed ID: 25081199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased miR-4512 Levels in Monocytes and Macrophages of Individuals With Systemic Lupus Erythematosus Contribute to Innate Immune Activation and Neutrsophil NETosis by Targeting TLR4 and CXCL2.
    Yang B; Huang X; Xu S; Li L; Wu W; Dai Y; Ge MX; Yuan L; Cao W; Yang M; Wu Y; Deng D
    Front Immunol; 2021; 12():756825. PubMed ID: 34721432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxidative Stress and Treg and Th17 Dysfunction in Systemic Lupus Erythematosus.
    Yang J; Yang X; Zou H; Li M
    Oxid Med Cell Longev; 2016; 2016():2526174. PubMed ID: 27597882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
    Wang H; Li T; Chen S; Gu Y; Ye S
    Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic lupus erythematosus: all roads lead to type I interferons.
    Pascual V; Farkas L; Banchereau J
    Curr Opin Immunol; 2006 Dec; 18(6):676-82. PubMed ID: 17011763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-mitochondrial autoantibodies in systemic lupus erythematosus and their association with disease manifestations.
    Becker Y; Loignon RC; Julien AS; Marcoux G; Allaeys I; Lévesque T; Rollet-Labelle E; Benk-Fortin H; Cloutier N; Melki I; Eder L; Wagner É; Pelletier M; Hajj HE; Tremblay MÈ; Belleannée C; Hébert MJ; Dieudé M; Rauch J; Fortin PR; Boilard E
    Sci Rep; 2019 Mar; 9(1):4530. PubMed ID: 30872710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathological mechanisms of abnormal iron metabolism and mitochondrial dysfunction in systemic lupus erythematosus.
    Wincup C; Sawford N; Rahman A
    Expert Rev Clin Immunol; 2021 Sep; 17(9):957-967. PubMed ID: 34263712
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.